GO
Loading...

Medtronic Inc

More

  • NEW YORK, Aug 13- Biotechnology company InterMune Inc is working with financial advisers to evaluate strategic options as it braces for potential takeover interest from larger drugmakers, people familiar with the matter said.

  • Early Glance: Medical Devices companies Wednesday, 13 Aug 2014 | 10:32 AM ET

    Allergan rose $1.27 or. 8 percent, to $154.31. Baxter International Inc. rose$. 49 or. 7 percent, to $74.76. Boston Scientific Corp. rose$. 01 or. 1 percent, to $12.39.

  • Final Glance: Medical Devices companies Monday, 11 Aug 2014 | 6:02 PM ET

    Allergan fell $3.44 or 2.2 percent, to $153.39. Baxter International Inc. rose$. 30 or. 4 percent, to $74.20. Boston Scientific Corp. fell$. 07 or. 6 percent, to $12.26.

  • Midday Glance: Medical Devices companies Monday, 11 Aug 2014 | 1:26 PM ET

    Allergan fell $3.20 or 2.0 percent, to $153.63. Baxter International Inc. rose$. 67 or. 9 percent, to $74.57. Boston Scientific Corp. rose$. 03 or. 2 percent, to $12.36.

  • Early Glance: Medical Devices companies Monday, 11 Aug 2014 | 10:35 AM ET

    Allergan fell $1.69 or 1.1 percent, to $155.14. Baxter International Inc. rose$. 51 or. 7 percent, to $74.41. Boston Scientific Corp. fell$. 07 or. 6 percent, to $12.26.

  • *Sanofi, MannKind aim to launch Afrezza in U.S. in Q1 2015. PARIS/ LONDON, Aug 11- French drugmaker Sanofi is betting on inhaled insulin as an alternative option to daily injections for diabetics by signing a worldwide licensing agreement with MannKind Corp worth up to $925 million.

  • Final Glance: Medical Devices companies Friday, 8 Aug 2014 | 6:06 PM ET

    Allergan rose $4.91 or 3.2 percent, to $156.83. Johnson& Johnson rose $1.15 or 1.2 percent, to $101.08. Medtronic rose $1.15 or 1.9 percent, to $62.15.

  • Midday Glance: Medical Devices companies Friday, 8 Aug 2014 | 1:51 PM ET

    Allergan rose $3.93 or 2.6 percent, to $155.85. Baxter International Inc. rose$. 10 or. 1 percent, to $73.87. Boston Scientific Corp. fell$. 11 or. 9 percent, to $12.16.

  • Early Glance: Medical Devices companies Friday, 8 Aug 2014 | 10:51 AM ET

    Allergan rose $2.31 or 1.5 percent, to $154.23. Baxter International Inc. fell$. 38 or. 5 percent, to $73.39. Boston Scientific Corp. fell$. 16 or 1.3 percent, to $12.10.

  • BOSTON, Aug 4- Cybersecurity researcher Ruben Santamarta says he has figured out how to hack the satellite communications equipment on passenger jets through their WiFi and inflight entertainment systems- a claim that, if confirmed, could prompt a review of aircraft security.

  • DUBLIN, July 30- Ireland is in the firing line from Washington again for luring U.S. companies to its shores for tax benefits, but despite contrite noises coming from Dublin, it has too much to lose to discourage U.S. firms bent on shifting their tax domiciles.

  • July 29- Edwards Lifesciences Corp posted stronger second-quarter earnings on Tuesday, propelled by a gain from a legal settlement and higher sales of heart valves that are implanted using a less-invasive procedure than traditional open-heart surgery.

  • July 29- Edwards Lifesciences Corp posted stronger second-quarter earnings on Tuesday, propelled by a gain from a legal settlement and higher sales of heart valves that are implanted using a less-invasive procedure than traditional open-heart surgery.

  • *By invoking 1969 law, Obama could bypass Congress- former Treasury official. *Treasury Secretary Lew renews call for urgent action by U.S. Congress.

  • WASHINGTON, July 28- President Barack Obama could act without congressional approval to limit a key incentive for U.S. corporations to move their tax domiciles abroad in so-called "inversion" deals, a former senior U.S. Treasury Department official said on Monday.

  • DUBLIN, July 25- Ireland defended its tax regime on Friday against criticism from U.S. Singling out Ireland for criticism, Obama on Thursday hammered U.S. companies that avoid federal taxes by shifting their tax domiciles overseas and called on Congress to pass a bill to curb such deals, known as "inversions".

  • Obama, Dems holding tax reform hostage: Norquist Friday, 25 Jul 2014 | 9:12 AM ET
    Grover Norquist, president of Americans for Tax Reform

    There's been "nothing, nothing, nothing, nothing" from Obama on corporate tax cuts in five years, Grover Norquist tells CNBC.

  • At least eight European law firms are pitching their services to major U.S. law firms and Wall Street banks, hoping that U.S. companies considering an inversion choose Ireland, Britain or the Netherlands for their new tax domicile, according to people with knowledge of the matter.

  • These deals may suffer in US ‘inversion’ crackdown Thursday, 24 Jul 2014 | 6:40 AM ET

    President Barack Obama’s push to deter U.S. firms from buying foreign companies for tax purposes will make several deals less attractive.

  • July 17- U.S. orthopedics company Stryker Corp on Thursday reported slightly higher second-quarter profit that was in line with Wall Street expectations and said it was always in the market for deals. In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion.